<DOC>
	<DOCNO>NCT00907764</DOCNO>
	<brief_summary>Regadenoson approve US brand name Lexiscan myocardial perfusion imaging . This study test whether regadenoson appropriate stress agent stress echocardiography .</brief_summary>
	<brief_title>Stress Echocardiography Study With Regadenoson</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>Patients clinically indicated dobutamine echocardiogram show normal wall motion rest abnormal wall motion stress Patients clinically indicate dipyridamole echocardiogram show normal perfusion wall motion rest abnormal perfusion without abnormal wall motion stress Any condition preclude safe administration dobutamine , dipyridamole SonoVue echocardiography Pregnant breastfeeding , ( premenopausal ) , practice acceptable method birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>